Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/7271
Title: An empirical study of voluntary research and development disclosures of biotechnology firms listed on NASDAQ
Authors: Gan, Peck Yen
Low, Calvin Sin Chye
Chim, Wai Kay
Keywords: DRNTU::Business::Accounting::Disclosure
Issue Date: 2000
Abstract: This empirical study attempts to establish the relationship between a firm's voluntary disclosures on research and development and its size, growth options, leverage and its independent auditor's reputation. Based on the results of this study, it was established that for biotechnology firms listed on Nasdaq, there exists a positive relationship between voluntary disclosures on R&D and growth options and/or with firm size. It was also shown that leverage was an insignificant factor in influencing firms' voluntary disclosures on research and development. Due to a lack in variance in data collected, the relationship between voluntary disclosures on research and development and independent auditor's reputation could not be established.
URI: http://hdl.handle.net/10356/7271
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:NBS Theses

Files in This Item:
File Description SizeFormat 
NBS-THESES_223.pdf
  Restricted Access
10.73 MBAdobe PDFView/Open

Page view(s) 50

245
Updated on Dec 1, 2020

Download(s)

2
Updated on Dec 1, 2020

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.